Logo of Huzzle

Cell Culture Development Intern

Applications are closed

  • Internship
    Full-time
    Summer Internship
  • Science
  • Minneapolis

Requirements

  • Must be a currently enrolled student pursuing a Bachelor's degree in a field relevant to the internship
  • Must have completed (at minimum) the sophomore year of college
  • Must have a current GPA of 3.0 or higher
  • Must be able to work full-time during the duration of the internship program
  • Experience Qualifications:
  • No experience is necessary beyond skills and knowledge that can be expected from completed coursework
  • Familiarity with aseptic techniques is preferred
  • Familiarity with basic molecular biology, microbiology, and protein chemistry techniques, is preferred
  • Familiarity with computer-based coding and data processing techniques, is preferred

Responsibilities

  • Study academic literature and apply gained information in daily work
  • Grow and maintain cultures for the purpose of recombinant protein expression, strain maintenance, and miscellaneous experiments
  • Propose, plan, and conduct experiments
  • Perform data analysis/entry, organize data, prepare charts, summaries, and reports. Share with peers.
  • Perform additional duties as assigned

Science & Healthcare
Industry
1001-5000
Employees

Mission & Purpose

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers, as well as clinical research laboratories, and constitute the Protein Sciences Segment. Bio-Techne also develops and manufactures diagnostic products including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for OEM and clinical customers. Bio-Techne’s genomic tools include advanced tissue-based in situ hybridization assays (ISH) for research and clinical use, sold under the ACD brand, as well as a portfolio of clinical molecular diagnostic oncology assays including the ExoDx®Prostate (IntelliScore) test (EPI) for prostate cancer diagnosis. These diagnostic and genomic products comprise Bio-Techne’s Diagnostics and Genomics Segment. Bio-Techne products are integral components of scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $714 million in net sales in fiscal 2019 and has over 2,200 employees worldwide.